LC-ESI-MS determination of quassinoids isobrucein B and neosergeolide in Picrolemma sprucei stem infusions by POHLIT, Adrian M. et al.
Article 
J. Braz. Chem. Soc., Vol. 20, No. 6, 1065-1070, 2009.
Printed in Brazil - ©2009  Sociedade Brasileira de Química
0103 - 5053  $6.00+0.00
*e-mail: npelopes@fcfrp.usp.br 
LC-ESI-MS Determination of Quassinoids Isobrucein B and Neosergeolide  
in Picrolemma sprucei Stem Infusions
Adrian M. Pohlit,a,b Valquíria A. P. Jabor,b Rodrigo C. das N. Amorim,a,c 
Ellen C. Costa e Silvaa,d and Norberto P. Lopesb,*
a Coordenação de Pesquisas em Produtos Naturais, Instituto Nacional de Pesquisas da Amazônia, 
Avenida André Araújo, 2936, 69060-001 Manaus-AM, Brazil
 
bDepartamento de Física e Química, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, 
Universidade de São Paulo, Avenida do Café, s/no, 14040-903 Ribeirão Preto-SP, Brazil 
cCurso de Pós-Graduação em Biotecnologia and d Curso de Pós-graduação em Química, 
Universidade Federal do Amazonas, 69077-000 Manaus-AM, Brazil
Infusões dos caules de Picrolemma sprucei (pseudônimo: P. pseudocoffea) são principalmente 
utilizadas como antimaláricos em toda região amazônica. Desta espécie foram isolados os 
quassinoides isobruceína B e neosergeolida, os quais apresentam atividade antimalárica e citotóxica. 
Neste estudo, apresentamos o desenvolvimento de uma metodologia analítica por LC-(+)-ESI-MS/
MS visando a determinação dos principais quassinoides desta espécie. O método desenvolvido 
foi empregado para análise de uma formulação artesanal (infusão de 1 g de matéria seca - caules 
pulverizados de P. sprucei em 1 L de água fervente). Padrões previamente isolados de isobruceína 
B e neosergeolida foram utilizados para a determinação da linearidade na faixa de calibração 
entre 0,25 to 5 µg mL-1 e 0,5 a 10 µg mL-1, respectivamente. Como padrão interno foi utilizada 
a substância fluoroglucinol na concentração de 4,0 µg mL-1. Ambos os compostos apresentaram 
boa linearidade, precisão e exatidão e as concentrações de isobruceína B e neosergeolida obtidas 
nas infusões foram de 60,1 e 774 µg L-1, respectivamente.
Infusions of the stems of Picrolemma sprucei (pseudonym: P. pseudocoffea) are used in 
the Amazon regions of Peru, Brazil and French Guiana as antimalarials among other uses. 
They contain the bitter quassinoids isobrucein B (1) and neosergeolide (2) that have important 
antimalarial and toxic properties among others. In this study, an LC-(+)-ESI-MS/MS method was 
developed and applied to the determination of 1 and 2 in a common remedy prepared by infusing 
1 g of dry, powdered stems of P. sprucei in 1 L of boiling water. Isolated 1 and 2 were used in 
calibration ranges of 0.25 to 5 µg mL-1 and 0.5 to 10 µg mL-1, respectively, with the internal 
standard phloroglucinol at 4.0 µg mL-1. Good linearity, precision and accuracy were observed for 
both compounds. The concentrations of 1 and 2 in the stem infusions were found to be 60.1 and 
774 µg L-1, respectively.
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Introduction
One of the classic goals of the Brazilian natural products 
research community is the search for new biologically 
active compounds.1 More recently, new interests include 
investigations of daily and seasonal rhythms of secondary 
metabolite biosyntheses and quality control of medicinal 
plants.2 Picrolemma sprucei Hook. f. (Simaroubaceae) is 
one of several medicinal plant species which are known 
in the Brazilian Amazon by the common name caferana 
(meaning “false-coffee”, and giving rise to the often used 
pseudonym for this plant, P. pseudocoffea Ducke). It is 
widely distributed throughout the Amazon region from 
Peru where it is popularly known as sacha-café3 to French 
Guiana where it is called café lane.4,5 Root, stem and 
whole plant infusions of P. sprucei are used throughout 
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the Amazon region in the treatment of malaria,6 gastro-
intestinal problems and intestinal worms.3 At higher doses, 
P. sprucei infusions have notable toxic effects and are used 
to provoke abortions.7
Recently, P. sprucei has been the subject of several 
studies whose results in general lend support to its uses in 
traditional medicine. For example, leaf and stem infusions 
and other extracts have been shown to possess in vitro 
antihelminthic activity.8 Also, an ethnopharmacological 
study in French Guiana showed that alcohol extracts 
of P. sprucei root, stem and bark are used in local 
traditional medicine as a curative treatment for malaria 
in association with Geissospermum spp. (Apocynaceae) 
and Quassia amara (Simaroubaceae) or modern drugs.5 
In a subsequent study, Bertani et al.9 demonstrated that a 
P. sprucei water extract can inhibit hemozoin formation 
and in vitro assays demonstrated the antimalarial activity 
of this extract against the chloroquine-resistant Plasmodium 
falciparum strain W2. In the western Brazilian Amazon, 
dried stems are commonly commercialized in local 
marketplaces by traditional healers or raizeiros and are 
typically used in the preparation of infusions for oral 
ingestion.
Infusions of P. sprucei contain the quassinoids 
isobrucein B (1) and neosergeolide (2) (Figure 1). These 
compounds have been isolated previously from the stems 
and roots of P. sprucei on a milligram scale10 and more 
recently on a gram-scale.11 Also, 1 has been isolated 
from the leaves of this plant.12 Recently, the antimalarial, 
antileukemic, antifeedant and leishmanicidal activities of 
1 were the subject of a review.13 Finally, 1 and 2 display 
significant cytotoxicity to human tumor cell lines, no 
hemolytic activity to mouse erythrocytes, and moderate 
larvicidal activity towards Aedes aegypti (hemorrhagic 
dengue fever vector).14
Considering the biological activities of P. sprucei 
and of the quassinoids isolated from it, together with the 
possible occurrence of seasonal and circadian variation, 
stimulates and justifies the development of analytical 
methods for the quantification of these active metabolites 
in infusions used in traditional medicine. Liquid 
chromatography (LC) coupled to mass spectrometry 
(LC-MS) has emerged as the most specific analytical 
method for qualitative and quantitative analyses of natural 
products.15 Additionally, advances in the elucidation of 
electrospray ionization (ESI) processes have allowed for 
the analysis of metabolites with less competition from 
low oxidative potential processes through molecular ion 
dissociation16 in addition to the well established acid-base 
and cationizing (anionizing) reactions.17 For these reasons, 
LC-ESI-MS predominates in Brazil and around the world 
as the technique of choice in the analysis of natural 
products of low-volatility in polar analytes of diverse 
origins.1 Given the range of dosages of traditionally used 
infusions of P. sprucei, the toxic effects associated with 
larger doses, and the ability of ESI coupled systems to 
analyze natural products, the aim of the present study was 
to develop a new method for determination of 1 and 2 in 
infusions of stems of P. sprucei.
Experimental
Collection of plant materials
Collection was performed in Silves, Amazonas 
State, Brazil, in April, 2003. Voucher specimens are on 
deposit at the UFAM Herbarium (Silva 5729 & 5730). 
Identification of P. sprucei Hook. f. was performed by Dr. 
Wayt Thomas.18 
Chemicals and reagents
Methanol, HPLC grade, was purchased from J.T.Baker 
(Xalostoc, Mexico). Glacial acetic acid was of analytical 
grade and supplied by Merck (Darmstadt, Germany). 
Ultrapure water, obtained from a Milli-Q Plus System 
(Millipore, Bedford, MA, USA), was used in all analyses. 
1 and 2 were isolated from P. sprucei as described 
previously11,19 and used as reference standards. Their 
identity and purity were established based on 1D 
and 2D NMR, IR, HR-ESI-TOF-MS, HPLC-DAD and 
LC-ESI-MS analyses and comparison to literature data.20
Standard solutions
Stock standard solutions were prepared at 1 mg mL-1 
in methanol and stored at -20 °C for a maximum of three 
months. Working solutions were prepared by appropriate 
dilution with methanol to have final concentrations in 
the ranges 0.25 to 5 µg mL-1 and 0.5 to 10 µg mL-1 for 1 
and 2, respectively. Working solutions had the internal 
standard (IS) phloroglucinol (1,3,5-trihydroxybenzene) at 
a concentration of 4.0 µg mL-1. 
Figure 1. Quassinoids isobrucein B (1) and neosergeolide (2) present in 
infusions of Picrolemma sprucei. 
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LC and MS detection conditions
The liquid chromatography system consisted of an 
LC-10AD pump and a CTO-10AS column oven from 
Shimadzu (Kyoto, Japan). The separation of 1, 2 and 
IS were performed on a reversed phase NST18 column, 
250 mm × 4.6 mm ID, 5 µm particle size (Nano Separation 
Technologies, São Carlos, São Paulo, Br). A LiChrospher 
100 RP 18 column, 4 mm × 4 mm ID, 5 µm particle size, 
from Merck (Darmstadt, Germany) was used as guard 
column. The LC system was operated isocratically using 
mobile phase consisting of a mixture of methanol:water 
(50:50, v/v) and 2 % acetic acid which was pumped at 
a flow-rate of 0.8 mL min-1. Injections of samples were 
performed manually through a 20 µL loop with a Rheodyne 
model 7125 injector (Rheodyne, Cotati, USA) and the 
column was kept in an oven set at 27±1 °C.
Detection was achieved with a Quattro Micro LC triple 
quadrupole mass spectrometer (Micromass, Manchester, 
UK) fitted with an electrospray interface (ESI) source and 
tandem mass separation operated in the positive ion mode 
at a potential of 2.5 kV. The LC flow was split so that 
approximately 150 µL min-1 entered the mass spectrometer. 
The desolvation temperature was set to 250 °C and the source 
was set to 100 °C for LC-MS. The nitrogen desolvation 
and nebulizer gas flow rates were set to 250 and 20 L h-1, 
respectively. Argon gas was used as collision gas. Cone 
voltage and collision energy were optimized for each analyte 
by performing full scan acquisitions. Optimization of MS 
conditions was achieved by direct infusion of standard 
solutions (10 µg mL-1) prepared in the mobile phase and 
delivered by a syringe pump at a flow-rate of 10 µL min-1. 
The cone voltage was set at 40 V for 1 and 2 and 20 V for 
IS, and collision energies of 20 eV for 1 and IS and 28 eV 
for 2 were used. For quantitation, MS/MS was operated in 
the multiple reaction monitoring (MRM) mode, monitoring 
the transitions 481>403, 505>225 and 127>81 for 1, 2 and 
IS, respectively, with a dwell time of 1.0 s. Data acquisition 
and quantitative analysis were performed using a MassLynx 
(Micromass) data acquisition system, version 4.1. 
Validation of the method
The method was rigorously validated in accordance 
with United States Food and Drug Administration (FDA) 
guidelines21 by determination of the following parameters: 
linearity, range, precision, accuracy, limit of quantification 
(LOQ) for LC-MS/MS. For linearity and range, the 
calibration curves were constructed by injection of seven 
concentrations of 1 and 2, ranging from 0.25 to 5.0 µg mL-1 
and 0.5 to 10 µg mL-1, respectively, in triplicate.
The analyte to IS peak area ratio was plotted against 
the respective standard concentrations and the linearity was 
evaluated by linear regression analysis. The acceptance 
criterion for each calculated standard concentration was a 
maximum 2% deviation from the nominal value, except for 
the LOQ, which was set as 10 % deviation. The precision 
of the method was determined by evaluating repeatability 
and LOQ was established using the criterion that responses 
of the analytes at the LOQ should be at least 5 times that 
of the blank response.
Sample preparation 
5.00 g of dry, ground stems of Picrolemma sprucei 
were infused in 1.00 L of boiling water. The resulting 
mixture was covered, allowed to stand for 15 min, then 
immediately filtered. The filtrate was evaporated to 
dryness under vacuum which resulted in a residue. The 
residue was dissolved in methanol in an ultrasound bath 
which provided a solution (10.0 mL) which was filtered. 
The resulting filtrate or RSI (residue of stem infusion in 
methanol solution) was stored at –20 °C and IS was added 
prior to LC-MS analysis. The concentration of quassinoids 
was calculated from the linear regression equations.
Results and Discussion
Development of LC-ESI-MS conditions
In order to quantify 1 and 2 in an infusion of stems of 
P. sprucei used in Brazilian folk medicine, MS parameters 
were optimized in order to obtain more abundant precursor 
ions. Thus, the balance of protonated or deprotonated and 
cationized or anionized 1 and 2 or other adduct ion species 
of 1 and 2 were analyzed. Ideally, these species should be 
of high intensity to allow analytes to be detected at low 
concentrations in complex matrices. The intensity of ion 
species was therefore the main criteria for optimization. 
Initially, 1 and 2 were directly infused into the MS detector 
using ESI ionization. Both positive and negative ionization 
modes of the ESI source were tested by infusion of standard 
solutions of each compound at 10 µg mL-1. The positive ion 
detection mode offered higher sensitivity than the negative 
mode using an acidic mobile phase. (+)-ESI-MS full scan 
spectra displayed protonated ions ([M+H]+) with good 
intensities at m/z 481 and 505 for 1 and 2, respectively. 
During the optimization of the method, different LC 
conditions and solvent systems were evaluated. Addition of 
acidic modifiers such as acetic acid to the mobile phase was 
found to improve peak resolution. Furthermore, the positive 
ion detection mode [(+)-ESI] offered higher sensitivity than 
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negative ion mode [(-)-ESI] when acidic mobile phase was 
used. Also, addition of acetic acid or formic acid to the 
mobile phase led to significant enhancement of the [M+H]+ 
ions and significant reduction of the cationized molecules. 
Table 1 presents the parent and fragment ions used for 
identification and quantification of compounds 1 and 2.
Stem infusion in solution (RSI) was directly injected 
into the LC-ESI-MS/MS system. Figure 2 presents the 
representative MRM-chromatogram. Under the conditions 
described in the method, IS, 1 and 2 eluted at retention 
times of 3.5, 4.6 and 8.6 min, respectively, and elution of 
all components of the sample was complete within 10 min. 
Chromatographic profiles displayed good separation of the 
analyte components in a short period of time.
Method validation
The validation parameters were evaluated through 
estimation of linearity, precision (intra and inter day) and 
accuracy of the method. The linearity of an analytical 
method is its ability, within a definite range, to obtain results 
directly proportional to the concentrations (quantities) of 
the analyte in the sample. The calibration curve for each 
analyte was based on 7 different concentrations by plotting 
the result of the linear regression analysis of the peak area 
ratio versus concentration.
Linear regression analysis provided the equations 
presented in Tables 2 and 3. For both 1 and 2, the 
correlation coefficients (r2) were evidence for a linear 
relationship between concentration and peak area ratio in 
the concentration range studied. The values of LOQ are also 
presented in tables 2 and 3 and were considered satisfactory 
for both analytes. 
Application of the method
In order to check the applicability of the developed 
method, a stem infusion was evaluated. This particular 
preparation was chosen based on the wide availability of 
stems in marketplaces in the western Brazilian Amazon and 
the use of this preparation as an antimalarial in traditional 
medicine in this region. Concentrations of 1 and 2 in samples 
of stem infusion were calculated based on the integration 
of the [M+H]+ peak area ratio of each of these analytes in 
the MRM chromatogram. By this process it is possible to 
select the compound of interest and quantification of the 
Table 1. Protonated molecule and fragment ions obtained in ESI-MS/MS 
spectra. The most stable and intensive ions (*) were used for identification 
and quantification of isobrucein B (1) and neosergeolide (2) by 
LC-ESI-MS/MS 
Quassinoid
1 2
Protonated molecule [M+H]+ 481 505
Fragment ions 463 487
445 463
439 445
421 427
403* 417
391 413
375 398
357 379
356 367
311 348
301 339
299 323
284 321
279 319
214 227
225*
Figure 2. Representative chromatogram. (A) Total ion count. (B) MRM 
of neosergeolide (2), (C) MRM of isobrucein B (1) and (D) MRM 
of the internal standard phloroglucinol (1,3,5-trihydroxybenzene). 
Chromatographic conditions: reversed phase NST18 column, 250 mm x 
4.6 mm ID, 5 µm. Eluents were methanol:water (50:50, v/v) and 2% acetic 
acid. Flow rate was 0.8 mL min-1. Injection volume was 20 µL. Column 
oven temperature was set at 27±1 °C.
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Conclusion
The LC-(+)-ESI-MS/MS method described herein 
proved suitable for the analysis of 1 and 2 in stem extracts 
and can be easily applied in routine analyses. Furthermore, 
the method may be used to certify the quality of popular 
medicinal uses of the extract and for ecological studies.
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